KARBE FRANK - Insider Non-Derivative Transactions at Better Therapeutics, Inc. (BTTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 18, 2023, KARBE FRANK's relationship to Better Therapeutics, Inc. (BTTX) is Director,Officer (Chief Executive Officer), and currently has 526,516 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BTTX insiders.
Data Source: SEC.
KARBE FRANK - Insider Non-Derivative Transactions of BTTX Common Stock
KARBE FRANK - Insider Non-Derivative Transactions at BTTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 19, 2023 | Acquisition -- (Common Stock) | 62500 | 0 | 526516 |
| Jul 28, 2023 | P -- (Common Stock) | 137005 | 0.73 | 429429 |
| Apr 11, 2023 | P -- (Common Stock) | 242424 | 0.83 | 292424 |